Abstract: Anemia is a common complication in end-stage renal disease patients. Currently, the percentage of hemodialysis patients with targeted hemoglobin concentration is still low in many areas in China. Appropriate anemia management is an important issue in the care of hemodialysis patients. For clinicians, awareness of anemia treatment, assessment of the interference factors on hemopoiesis, careful monitoring of hematological parameters, individualized management, and all efforts to achieve targeted hemoglobin concentration should be emphasized to raise the quality of life and to reduce complications and mortality in these patients.

Key words: Hemodialysis, Anemia, Erythropoiesis stimulating agents